| 谈药品商品名的保护与“在先权利”的关系——从一个案例谈起 |
| |
| 引用本文： | 瞿友胜.谈药品商品名的保护与“在先权利”的关系——从一个案例谈起[J].中国专利与商标,2009(2):59-65. |
| |
| 作者姓名： | 瞿友胜 |
| |
| 作者单位： | 东莞市中正知识产权事务所主任 |
| |
| 摘 要： | 根据我国药品管理的有关规定，使用药品名称必须得到国家药监部门的批准，药品名称包括药品的通用名称和药品商品名。我国《药品管理法》与《商标法》都明确规定，药品的通用名称不能作为商标注册，但以药品商品名申请注册商标，不在禁止之列，甚至得到国家药监部门的支持。
|
| 关 键 词： | 药品管理法 商品名 通用名称 案例 权利 保护 《商标法》 商标注册 |
Relations of Protection of Commodity Names of Drugs with ＂Prior Right＂, from Perspective of Case Study |
| |
| Authors: | Qu Yousheng |
| |
| Institution: | Qu Yousheng(Director of the Zhongzheng Intellectual Property Law Office of Dongguan City) |
| |
| Abstract: | Under the relevant provisions concerning pharmaceuticals or drug administration in China, use of the name of a pharmaceutical or drug must be approved by the State drug supervision agency. The names of drugs include generic names and names of goods of pharmaceuticals or drugs. It is expressly provided in the Drug Administration Law and the Trademark Law that a generic name of a drug should not be applied for registration as a mark; but application for registration of a commodity name of drug is not precluded or prohibited; |
| |
| Keywords: | |
| 本文献已被 维普 等数据库收录！ |
